Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.
about
Noninvasive imaging modalities to visualize atherosclerotic plaquesPET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to PathophysiologyNuclear Molecular Imaging for Vulnerable Atherosclerotic PlaquesNon-invasive anatomic and functional imaging of vascular inflammation and unstable plaqueExploring the nature of atheroma and cardiovascular inflammation in vivo using positron emission tomography (PET)Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission tomographyNon-invasive vulnerable plaque imaging: how do we know that treatment works?Periaortic brown adipose tissue as a major determinant of [¹⁸F]-fluorodeoxyglucose vascular uptake in atherosclerosis-prone, apoE-/- miceRecent developments in vascular imaging techniques in tissue engineering and regenerative medicine.Multimodality imaging of lower extremity peripheral arterial disease: current role and future directions.Correlation between arterial FDG uptake and biomarkers in peripheral artery disease.Multimodality cardiovascular molecular imaging, Part IICardiovascular molecular imaging: focus on clinical translationPhotoacoustic imaging and characterization of the microvasculatureMolecular imaging in atherosclerosis.Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques?Quantitative carotid PET/MR imaging: clinical evaluation of MR-Attenuation correction versus CT-Attenuation correction in (18)F-FDG PET/MR emission data and comparison to PET/CTOptimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels.Bioenergetic profiles diverge during macrophage polarization: implications for the interpretation of 18F-FDG PET imaging of atherosclerosisFeasibility of in vivo 18F-florbetaben PET/MR imaging of human carotid amyloid-βImaging of atherosclerosisInflammation in atherosclerosis: from pathophysiology to practiceInflammation imaging in atherosclerosisRationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomographyPET probes for distinct metabolic pathways have different cell specificities during immune responses in miceEvaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis.Reproducibility of black blood dynamic contrast-enhanced magnetic resonance imaging in aortic plaques of atherosclerotic rabbits.Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE studyMacrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosisSafety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.Increased microvascularization and vessel permeability associate with active inflammation in human atheromata.PET/CT imaging of chemokine receptor CCR5 in vascular injury model using targeted nanoparticle.(18)F-FDG PET and vascular inflammation: time to refine the paradigm?(64)Cu-labeled LyP-1-dendrimer for PET-CT imaging of atherosclerotic plaqueRelationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging studyMolecular imaging of atherosclerotic plaque with (64)Cu-labeled natriuretic peptide and PETImplications of Pericardial, Visceral and Subcutaneous Adipose Tissue on Vascular Inflammation Measured Using 18FDG-PET/CT.Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy.Aortic ¹⁸F-FDG uptake in patients suffering from granulomatosis with polyangiitis.Feasibility of (18)F-Fluorodeoxyglucose radiotracer dose reduction in simultaneous carotid PET/MR imaging
P2860
Q26738579-CF35BEEF-EAAB-4232-B1E3-EF7E4457CAE6Q26750798-EE2D847B-7405-490E-9FE5-AA6E03B5C03FQ26781838-F1691C5A-F2B2-412F-803A-FB81E5554DCDQ26824883-4289FDCA-5648-43D1-B503-0751DC94BBE2Q26852635-258C3399-BDF5-4D6C-BC6C-EF22209933CEQ26865857-ADDE773F-37B3-424E-B2DA-EA3812288BC4Q27020959-1D9D5BE0-B536-4DF7-B19E-18E3CB5A66FBQ27324089-A30583EA-18F9-4225-B778-60C9D279C27DQ30415772-84862E2C-A975-4419-BA20-6D8FDFA52768Q30416517-B8A98DF1-3B55-48FA-8028-151C4E5D9963Q30436195-F837644B-AEE1-465A-BA7B-24FCC4B6050BQ30438207-4F7D8882-E709-4CC1-9B4B-B7C0860AA5F7Q30470859-250F77ED-649C-4B7C-B8FE-C975206D4CE0Q30477501-99A8CDF1-CA4E-4C0D-9F2C-D158885EA11FQ30478541-4EAA32ED-934A-428E-8668-B7E2DAF6802EQ30479243-91241EC1-0B32-447C-9623-DA21DF09E5C3Q30970716-C850F404-FA73-4EF7-A0C5-F78D1C1E8923Q33624365-758DA8E8-697F-4865-9E5B-58493BDD3272Q33679420-981B3853-EBB1-4E0F-9D26-024892341E8EQ33695086-E4B051A0-42A7-4A2E-8A16-51CCB56023B3Q33697215-1062BD85-9FC8-4251-9180-597449A2AF8FQ33709505-7A853646-4B52-4ACA-887C-08E710E1E458Q33719461-40A8D5C3-708B-45A4-9F21-4FD33C470F02Q33719962-BB0E95E3-34F9-4B27-8180-F9D1B4A183AEQ33881305-C0E6A5D2-F144-4E62-9472-78030193F517Q33908068-423E954E-8CC0-4679-9166-A1A7FDF1860DQ33949993-7D1E951D-CD48-46B2-9E10-2ED3650E7ABAQ33956714-CD3ACE5F-B858-4579-BB53-AF20159A36FCQ34004031-B3271A86-5F6A-44D5-90CC-EB261F9A7FBBQ34120778-B7F81E54-E666-4A24-832F-AA1F04F89D2CQ34543441-68A89375-738E-4119-A5E0-87D67946E6D0Q34632459-1ACA904F-77F0-4BC3-B2A2-11143998C3CEQ34694001-66722316-8243-4FAE-ACEC-9E3E66B02097Q35030851-56A7B5BA-0CA2-4915-AAAC-5573FD89397EQ35303221-86FB4005-372E-4771-B07B-E943EE71ACF8Q35540268-05109AF4-A3B4-4E88-8027-7C07CDF3FCA4Q35744851-15AB8C02-3568-4BEF-A7B8-F09773BCC0EEQ35831733-F858F11A-8881-44A3-8A79-CA86D3407A11Q35851713-97CCA50E-8992-4E9E-B3EC-B5A1E2A98B67Q35929734-B334BA32-6E39-469A-A54D-631CBFE7F274
P2860
Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Atherosclerosis inflammation i ...... methods, and recommendations.
@en
type
label
Atherosclerosis inflammation i ...... methods, and recommendations.
@en
prefLabel
Atherosclerosis inflammation i ...... methods, and recommendations.
@en
P2093
P1476
Atherosclerosis inflammation i ...... methods, and recommendations.
@en
P2093
Ash Rafique
Cathy Anne Pinto
James H F Rudd
Josef Machac
Kelly S Myers
Michael Farkouh
Richard Hargeaves
Sameer Bansilal
Zahi A Fayad
P304
P356
10.2967/JNUMED.107.050294
P407
P577
2008-05-15T00:00:00Z